On the morning of August 1, the 2020 Hefei High-tech Zone "Yangtze River Delta Regional Medical Device Registrant System" Policy Interpretation and Theme Seminar hosted by the Management Committee of Hefei High-tech Zone, hosted by the High-tech Zone Investment Promotion Bureau and High-tech Company, was held in the High-tech Zone Held in the conference hall on the first floor of Building B of the Management Committee. Zhu Dehong, deputy director of the Medical Device Production Supervision Division of Anhui Provincial Food and Drug Administration, Xiang Min, member of the Working Committee and deputy director of the Management Committee of Hefei High-tech Zone, the person in charge of the Investment Promotion Bureau of the High-tech Zone, and the person in charge of Gaochuang shares attended the meeting. More than 60 corporate executives from the medical technology and medical device industries in the high-tech zone attended the meeting.

During the meeting, Xiangmin first delivered a speech on behalf of the high-tech zone. He introduced to the participating companies that the life and health industry is becoming a new engine for the development of modern economy in Hefei high-tech zone. Hefei High-tech Zone continues to promote the agglomeration of industrial elements, and has successively been approved as the Central Center of National Health and Medical Big Data, Anhui Biomedicine and High-end Medical Devices Agglomeration Development Base, and Hefei Health and Medical Town. The overall scale of the biomedical industry has maintained stable growth. In 2019, there are more than 250 enterprises in the life and health industry in the high-tech zone, with an industrial scale of more than 17 billion yuan and a growth rate of more than 15%. Precision medicine and health big data rank among the forefront of the national industry. Entrepreneurs and experts from the medical device industry gathered at this event to discuss the development prospects of the medical device industry, which has very important guiding value for the high-tech zone to accelerate the development of the biomedical industry. It is hoped that the leaders and experts attending the meeting will help Hefei High-tech Zone to come up with more "golden ideas" and "smart ideas" to promote the development of the biomedical industry, and help the High-tech Zone to accelerate the construction of a world-class high-tech park.

The meeting invited Zhu Dehong, deputy director of the Medical Device Production Supervision Division of the Anhui Provincial Food and Drug Administration, to give an in-depth interpretation of the "Implementation Plan for the Pilot Work of the Medical Device Registrant System in the Yangtze River Delta Region" to participating companies. Previously, medical device product registration (marketing) and medical device production license (production) must be the same subject, and the implementation of the registrant system will "unbundle" the two. From a macro perspective, the layout of the medical device industry will be further subdivided , medical device registration applicants in the Yangtze River Delta region can entrust manufacturers in the Yangtze River Delta region to produce products, and the allocation of cross-regional social resources will be further optimized, and R&D and production will perform their respective duties. Zhu Chu also said in the lecture that the Anhui Provincial Food and Drug Administration will attach great importance to the prevention and control of medical device supervision risks, implement scientific and effective supervision concepts, improve work efficiency, provide an excellent business environment for industrial development, and fully release policy dividends .

 In the case sharing session, Pang Yonggang, Chairman of Jiangsu Qihao Medical Technology Co., Ltd. was invited to share the company's successful experience after the implementation of the MAH system for medical devices.

 The final theme roundtable dialogue was hosted by Li Qiang, general manager of Guangzhou Jiutai Pharmaceutical Technology Co., Ltd. Pang Yonggang, chairman of Jiangsu Qihao Medical Technology Co., Ltd., Wang Zhongliang, chairman of Anhui Huibang Bioengineering Co., Ltd., and general manager of Anhui Shenlan Medical Technology Co., Ltd. Manager Zhang Chao and Chairman Zhu Qi of Hefei Xingzhi Biotechnology Co., Ltd. jointly discussed the development prospects of the medical device industry after the release of the "Yangtze River Delta Regional Medical Device Registrant System" policy.

Through this seminar, the detailed interpretation of the "Yangtze River Delta Regional Medical Device Registrant System", the sharing of successful industry cases and the discussion and exchange of the future development of the medical device industry will not only help medical device companies in the high-tech zone to better understand the registrant system And the opportunities and challenges it brings, the implementation of the system will also further integrate the resources of the medical device industry chain in the Yangtze River Delta region, and promote the coordinated high-quality development of the medical device industry in the high-tech zone and the Yangtze River Delta region.